OraSure to Participate in Upcoming Investor Conference

Rhea-AI Summary

OraSure Technologies (NASDAQ: OSUR) has announced its participation in the upcoming Stephens Annual Investment Conference on Wednesday, November 20. The company will engage in a Q&A session scheduled for 1 p.m. ET. Investors can access a live webcast and replay of the session through OraSure's investor relations webpage. The webcast recording will remain available for approximately 90 days following the event.

News Market Reaction – OSUR

+2.93%

+2.93% Session move

In the trading session that priced this news, OSUR gained 2.93%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BETHLEHEM, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference:

• Stephens Annual Investment Conference on Wednesday, November 20, with a Q&A session scheduled for 1 p.m. ET
  

A live webcast and replay of the Q&A session will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. The webcast will be archived on OraSure’s website and will be available for approximately 90 days.

About OraSure Technologies, Inc. 
OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiary, DNA Genotek Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.                                           

Investor Contact: Jason Plagman  VP, Investor Relations investorinfo@orasure.com

Media Contact: Amy Koch Director, Corporate Communications media@orasure.com

FAQ

When is OraSure (OSUR) presenting at the Stephens Annual Investment Conference?

OraSure (OSUR) is scheduled to present at the Stephens Annual Investment Conference on Wednesday, November 20, with a Q&A session at 1 p.m. ET.

How long will the OraSure (OSUR) Stephens Conference webcast be available?

The webcast will be archived on OraSure's website for approximately 90 days after the event.

Where can I watch OraSure's (OSUR) Stephens Conference presentation?

The live webcast and replay will be available on OraSure's investor relations website at https://orasure.gcs-web.com/events-and-presentations.